351 related articles for article (PubMed ID: 17409398)
1. Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system.
Pirollo KF; Rait A; Zhou Q; Hwang SH; Dagata JA; Zon G; Hogrefe RI; Palchik G; Chang EH
Cancer Res; 2007 Apr; 67(7):2938-43. PubMed ID: 17409398
[TBL] [Abstract][Full Text] [Related]
2. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
Yoshizawa T; Hattori Y; Hakoshima M; Koga K; Maitani Y
Eur J Pharm Biopharm; 2008 Nov; 70(3):718-25. PubMed ID: 18647651
[TBL] [Abstract][Full Text] [Related]
3. [Experimental study of MAT1 gene silencing mediated by siRNA in pancreatic cancer].
Liu JP; Yuan SZ; Zhang SN
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2719-23. PubMed ID: 18167254
[TBL] [Abstract][Full Text] [Related]
4. Targeted delivery of small interfering RNA: approaching effective cancer therapies.
Pirollo KF; Chang EH
Cancer Res; 2008 Mar; 68(5):1247-50. PubMed ID: 18316585
[TBL] [Abstract][Full Text] [Related]
5. Calcium carbonate nanoparticle delivering vascular endothelial growth factor-C siRNA effectively inhibits lymphangiogenesis and growth of gastric cancer in vivo.
He XW; Liu T; Chen YX; Cheng DJ; Li XR; Xiao Y; Feng YL
Cancer Gene Ther; 2008 Mar; 15(3):193-202. PubMed ID: 18202713
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.
Landen CN; Chavez-Reyes A; Bucana C; Schmandt R; Deavers MT; Lopez-Berestein G; Sood AK
Cancer Res; 2005 Aug; 65(15):6910-8. PubMed ID: 16061675
[TBL] [Abstract][Full Text] [Related]
7. Tumor-targeting nanoimmunoliposome complex for short interfering RNA delivery.
Pirollo KF; Zon G; Rait A; Zhou Q; Yu W; Hogrefe R; Chang EH
Hum Gene Ther; 2006 Jan; 17(1):117-24. PubMed ID: 16409130
[TBL] [Abstract][Full Text] [Related]
8. RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy.
Santel A; Aleku M; Keil O; Endruschat J; Esche V; Durieux B; Löffler K; Fechtner M; Röhl T; Fisch G; Dames S; Arnold W; Giese K; Klippel A; Kaufmann J
Gene Ther; 2006 Sep; 13(18):1360-70. PubMed ID: 16625242
[TBL] [Abstract][Full Text] [Related]
9. Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo.
Chien PY; Wang J; Carbonaro D; Lei S; Miller B; Sheikh S; Ali SM; Ahmad MU; Ahmad I
Cancer Gene Ther; 2005 Mar; 12(3):321-8. PubMed ID: 15578064
[TBL] [Abstract][Full Text] [Related]
10. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo.
Urban-Klein B; Werth S; Abuharbeid S; Czubayko F; Aigner A
Gene Ther; 2005 Mar; 12(5):461-6. PubMed ID: 15616603
[TBL] [Abstract][Full Text] [Related]
11. A tumor-targeted nanodelivery system to improve early MRI detection of cancer.
Pirollo KF; Dagata J; Wang P; Freedman M; Vladar A; Fricke S; Ileva L; Zhou Q; Chang EH
Mol Imaging; 2006; 5(1):41-52. PubMed ID: 16779969
[TBL] [Abstract][Full Text] [Related]
12. Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA.
Sabbioni S; Callegari E; Manservigi M; Argnani R; Corallini A; Negrini M; Manservigi R
Gene Ther; 2007 Mar; 14(5):459-64. PubMed ID: 17051250
[TBL] [Abstract][Full Text] [Related]
13. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
Guo B; Zhang Y; Luo G; Li L; Zhang J
Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
[TBL] [Abstract][Full Text] [Related]
14. Anticancer activity of RecQL1 helicase siRNA in mouse xenograft models.
Futami K; Kumagai E; Makino H; Sato A; Takagi M; Shimamoto A; Furuichi Y
Cancer Sci; 2008 Jun; 99(6):1227-36. PubMed ID: 18422747
[TBL] [Abstract][Full Text] [Related]
15. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer.
Jonson AL; Rogers LM; Ramakrishnan S; Downs LS
Gynecol Oncol; 2008 Nov; 111(2):356-64. PubMed ID: 18755502
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of non-small cell lung cancer cell proliferation and tumor growth by vector-based small interfering RNAs targeting HER2/neu.
Ren XL; Xu YM; Bao W; Fu HJ; Wu CG; Zhao Y; Li ZK; Zhang J; Li SQ; Chen WQ; Wang T; Zhang R; Zhang LH; Qian GS; Chen SY; Jia LT; Yang AG
Cancer Lett; 2009 Aug; 281(2):134-43. PubMed ID: 19339104
[TBL] [Abstract][Full Text] [Related]
17. A nanoparticle system specifically designed to deliver short interfering RNA inhibits tumor growth in vivo.
Yagi N; Manabe I; Tottori T; Ishihara A; Ogata F; Kim JH; Nishimura S; Fujiu K; Oishi Y; Itaka K; Kato Y; Yamauchi M; Nagai R
Cancer Res; 2009 Aug; 69(16):6531-8. PubMed ID: 19654315
[TBL] [Abstract][Full Text] [Related]
18. Suppression of progression and metastasis of established colon tumors in mice by intravenous delivery of short interfering RNA targeting KITENIN, a metastasis-enhancing protein.
Lee JH; Cho ES; Kim MY; Seo YW; Kho DH; Chung IJ; Kook H; Kim NS; Ahn KY; Kim KK
Cancer Res; 2005 Oct; 65(19):8993-9003. PubMed ID: 16204073
[TBL] [Abstract][Full Text] [Related]
19. Surface-modified LPD nanoparticles for tumor targeting.
Li SD; Huang L
Ann N Y Acad Sci; 2006 Oct; 1082():1-8. PubMed ID: 17145918
[TBL] [Abstract][Full Text] [Related]
20. A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy.
Mao CQ; Du JZ; Sun TM; Yao YD; Zhang PZ; Song EW; Wang J
Biomaterials; 2011 Apr; 32(11):3124-33. PubMed ID: 21277018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
